HEADER TRANSFERASE/TRANSFERASE INHIBITOR 23-SEP-22 8ELC TITLE HUMAN JNK2 BOUND TO COVALENT INHIBITOR YL2056 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 9; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAP KINASE 9,MAPK 9,JNK-55,STRESS-ACTIVATED PROTEIN KINASE COMPND 5 1A,SAPK1A,STRESS-ACTIVATED PROTEIN KINASE JNK2,C-JUN N-TERMINAL COMPND 6 KINASE 2; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK9, JNK2, PRKM9, SAPK1A; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS JNK2, YLIU2056, KINASE INHIBITOR, STRUCTURE-BASED DRUG DESIGN, KEYWDS 2 TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX, CELL CYCLE, TRANSFERASE- KEYWDS 3 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.LI,D.GURBANI,K.D.WESTOVER REVDAT 2 25-OCT-23 8ELC 1 REMARK REVDAT 1 28-JUN-23 8ELC 0 JRNL AUTH W.LU,Y.LIU,Y.GAO,Q.GENG,D.GURBANI,L.LI,S.B.FICARRO, JRNL AUTH 2 C.J.MEYER,D.SINHA,I.YOU,J.TSE,Z.HE,W.JI,J.CHE,A.Y.KIM,T.YU, JRNL AUTH 3 K.WEN,K.C.ANDERSON,J.A.MARTO,K.D.WESTOVER,T.ZHANG,N.S.GRAY JRNL TITL DEVELOPMENT OF A COVALENT INHIBITOR OF C-JUN N-TERMINAL JRNL TITL 2 PROTEIN KINASE (JNK) 2/3 WITH SELECTIVITY OVER JNK1. JRNL REF J.MED.CHEM. V. 66 3356 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 36826833 JRNL DOI 10.1021/ACS.JMEDCHEM.2C01834 REMARK 2 REMARK 2 RESOLUTION. 2.07 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.07 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.06 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 23912 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.780 REMARK 3 FREE R VALUE TEST SET COUNT : 1143 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.0600 - 4.1400 0.99 3055 146 0.1920 0.2333 REMARK 3 2 4.1400 - 3.2900 1.00 2938 151 0.1848 0.2537 REMARK 3 3 3.2900 - 2.8700 0.98 2852 150 0.2186 0.2573 REMARK 3 4 2.8700 - 2.6100 0.99 2878 129 0.2147 0.2661 REMARK 3 5 2.6100 - 2.4200 0.98 2809 158 0.2252 0.3107 REMARK 3 6 2.4200 - 2.2800 0.97 2764 152 0.2479 0.2846 REMARK 3 7 2.2800 - 2.1700 0.96 2751 137 0.2677 0.3079 REMARK 3 8 2.1700 - 2.0720 0.95 2722 120 0.2845 0.3412 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.739 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.65 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.94 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 3002 REMARK 3 ANGLE : 1.070 4070 REMARK 3 CHIRALITY : 0.054 445 REMARK 3 PLANARITY : 0.007 515 REMARK 3 DIHEDRAL : 11.613 396 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8ELC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-SEP-22. REMARK 100 THE DEPOSITION ID IS D_1000268705. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-DEC-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24374 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.072 REMARK 200 RESOLUTION RANGE LOW (A) : 47.060 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 2.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.07 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3NPC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M POTASSIUM PHOSPHATE DIBASIC, 20% REMARK 280 W/V POLYETHYLENE GLYCOL 3,350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.61750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.05850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.88050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.05850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.61750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.88050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ASP A 3 REMARK 465 SER A 4 REMARK 465 LYS A 5 REMARK 465 CYS A 6 REMARK 465 ASP A 7 REMARK 465 SER A 8 REMARK 465 GLU A 364 REMARK 465 GLU A 365 REMARK 465 ARG A 366 REMARK 465 SER A 367 REMARK 465 LYS A 368 REMARK 465 ASN A 369 REMARK 465 GLY A 370 REMARK 465 VAL A 371 REMARK 465 VAL A 372 REMARK 465 LYS A 373 REMARK 465 ASP A 374 REMARK 465 GLN A 375 REMARK 465 PRO A 376 REMARK 465 SER A 377 REMARK 465 ASP A 378 REMARK 465 ALA A 379 REMARK 465 ALA A 380 REMARK 465 VAL A 381 REMARK 465 SER A 382 REMARK 465 SER A 383 REMARK 465 ASN A 384 REMARK 465 ALA A 385 REMARK 465 THR A 386 REMARK 465 PRO A 387 REMARK 465 SER A 388 REMARK 465 GLN A 389 REMARK 465 SER A 390 REMARK 465 SER A 391 REMARK 465 SER A 392 REMARK 465 ILE A 393 REMARK 465 ASN A 394 REMARK 465 ASP A 395 REMARK 465 ILE A 396 REMARK 465 SER A 397 REMARK 465 SER A 398 REMARK 465 MET A 399 REMARK 465 SER A 400 REMARK 465 THR A 401 REMARK 465 GLU A 402 REMARK 465 GLN A 403 REMARK 465 THR A 404 REMARK 465 LEU A 405 REMARK 465 ALA A 406 REMARK 465 SER A 407 REMARK 465 ASP A 408 REMARK 465 THR A 409 REMARK 465 ASP A 410 REMARK 465 SER A 411 REMARK 465 SER A 412 REMARK 465 LEU A 413 REMARK 465 ASP A 414 REMARK 465 ALA A 415 REMARK 465 SER A 416 REMARK 465 THR A 417 REMARK 465 GLY A 418 REMARK 465 PRO A 419 REMARK 465 LEU A 420 REMARK 465 GLU A 421 REMARK 465 GLY A 422 REMARK 465 CYS A 423 REMARK 465 ARG A 424 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS A 116 C05 Y56 A 501 2.02 REMARK 500 O HOH A 604 O HOH A 637 2.03 REMARK 500 O HOH A 654 O HOH A 658 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE1 GLU A 100 NH1 ARG A 174 3555 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 204 CB GLU A 204 CG -0.143 REMARK 500 GLU A 204 CG GLU A 204 CD -0.113 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 17 -75.00 65.43 REMARK 500 SER A 18 -143.57 -89.01 REMARK 500 ARG A 59 58.37 36.89 REMARK 500 GLN A 102 -47.32 -138.70 REMARK 500 ARG A 150 -10.68 75.42 REMARK 500 ASP A 151 41.31 -140.79 REMARK 500 ASN A 179 -106.01 50.45 REMARK 500 MET A 181 -139.20 -154.76 REMARK 500 MET A 182 136.03 90.55 REMARK 500 TYR A 185 -157.00 -131.41 REMARK 500 GLN A 226 63.69 -102.78 REMARK 500 SER A 282 7.47 53.36 REMARK 500 GLU A 283 49.11 -107.90 REMARK 500 SER A 284 167.20 179.67 REMARK 500 HIS A 347 114.25 59.99 REMARK 500 REMARK 500 REMARK: NULL DBREF 8ELC A 1 424 UNP P45984 MK09_HUMAN 1 424 SEQRES 1 A 424 MET SER ASP SER LYS CYS ASP SER GLN PHE TYR SER VAL SEQRES 2 A 424 GLN VAL ALA ASP SER THR PHE THR VAL LEU LYS ARG TYR SEQRES 3 A 424 GLN GLN LEU LYS PRO ILE GLY SER GLY ALA GLN GLY ILE SEQRES 4 A 424 VAL CYS ALA ALA PHE ASP THR VAL LEU GLY ILE ASN VAL SEQRES 5 A 424 ALA VAL LYS LYS LEU SER ARG PRO PHE GLN ASN GLN THR SEQRES 6 A 424 HIS ALA LYS ARG ALA TYR ARG GLU LEU VAL LEU LEU LYS SEQRES 7 A 424 CYS VAL ASN HIS LYS ASN ILE ILE SER LEU LEU ASN VAL SEQRES 8 A 424 PHE THR PRO GLN LYS THR LEU GLU GLU PHE GLN ASP VAL SEQRES 9 A 424 TYR LEU VAL MET GLU LEU MET ASP ALA ASN LEU CYS GLN SEQRES 10 A 424 VAL ILE HIS MET GLU LEU ASP HIS GLU ARG MET SER TYR SEQRES 11 A 424 LEU LEU TYR GLN MET LEU CYS GLY ILE LYS HIS LEU HIS SEQRES 12 A 424 SER ALA GLY ILE ILE HIS ARG ASP LEU LYS PRO SER ASN SEQRES 13 A 424 ILE VAL VAL LYS SER ASP CYS THR LEU LYS ILE LEU ASP SEQRES 14 A 424 PHE GLY LEU ALA ARG THR ALA CYS THR ASN PHE MET MET SEQRES 15 A 424 THR PRO TYR VAL VAL THR ARG TYR TYR ARG ALA PRO GLU SEQRES 16 A 424 VAL ILE LEU GLY MET GLY TYR LYS GLU ASN VAL ASP ILE SEQRES 17 A 424 TRP SER VAL GLY CYS ILE MET GLY GLU LEU VAL LYS GLY SEQRES 18 A 424 CYS VAL ILE PHE GLN GLY THR ASP HIS ILE ASP GLN TRP SEQRES 19 A 424 ASN LYS VAL ILE GLU GLN LEU GLY THR PRO SER ALA GLU SEQRES 20 A 424 PHE MET LYS LYS LEU GLN PRO THR VAL ARG ASN TYR VAL SEQRES 21 A 424 GLU ASN ARG PRO LYS TYR PRO GLY ILE LYS PHE GLU GLU SEQRES 22 A 424 LEU PHE PRO ASP TRP ILE PHE PRO SER GLU SER GLU ARG SEQRES 23 A 424 ASP LYS ILE LYS THR SER GLN ALA ARG ASP LEU LEU SER SEQRES 24 A 424 LYS MET LEU VAL ILE ASP PRO ASP LYS ARG ILE SER VAL SEQRES 25 A 424 ASP GLU ALA LEU ARG HIS PRO TYR ILE THR VAL TRP TYR SEQRES 26 A 424 ASP PRO ALA GLU ALA GLU ALA PRO PRO PRO GLN ILE TYR SEQRES 27 A 424 ASP ALA GLN LEU GLU GLU ARG GLU HIS ALA ILE GLU GLU SEQRES 28 A 424 TRP LYS GLU LEU ILE TYR LYS GLU VAL MET ASP TRP GLU SEQRES 29 A 424 GLU ARG SER LYS ASN GLY VAL VAL LYS ASP GLN PRO SER SEQRES 30 A 424 ASP ALA ALA VAL SER SER ASN ALA THR PRO SER GLN SER SEQRES 31 A 424 SER SER ILE ASN ASP ILE SER SER MET SER THR GLU GLN SEQRES 32 A 424 THR LEU ALA SER ASP THR ASP SER SER LEU ASP ALA SER SEQRES 33 A 424 THR GLY PRO LEU GLU GLY CYS ARG HET Y56 A 501 44 HETNAM Y56 4-(DIMETHYLAMINO)-N-{4-[(3S)-3-({4-[(8R)-2- HETNAM 2 Y56 PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL]PYRIMIDIN-2- HETNAM 3 Y56 YL}AMINO)PYRROLIDINE-1-CARBONYL]PHENYL}BUTANAMIDE FORMUL 2 Y56 C34 H36 N8 O2 FORMUL 3 HOH *73(H2 O) HELIX 1 AA1 ASN A 63 LEU A 77 1 15 HELIX 2 AA2 LEU A 115 ILE A 119 1 5 HELIX 3 AA3 HIS A 120 GLU A 122 5 3 HELIX 4 AA4 ASP A 124 ALA A 145 1 22 HELIX 5 AA5 LYS A 153 SER A 155 5 3 HELIX 6 AA6 ALA A 193 LEU A 198 1 6 HELIX 7 AA7 ASN A 205 GLY A 221 1 17 HELIX 8 AA8 ASP A 229 GLY A 242 1 14 HELIX 9 AA9 SER A 245 LYS A 251 1 7 HELIX 10 AB1 GLN A 253 ASN A 262 1 10 HELIX 11 AB2 LYS A 270 PHE A 275 1 6 HELIX 12 AB3 PRO A 276 PHE A 280 5 5 HELIX 13 AB4 SER A 284 LEU A 302 1 19 HELIX 14 AB5 SER A 311 ARG A 317 1 7 HELIX 15 AB6 ILE A 321 TYR A 325 5 5 HELIX 16 AB7 ASP A 326 GLU A 331 1 6 HELIX 17 AB8 ALA A 340 ARG A 345 1 6 HELIX 18 AB9 ALA A 348 ASP A 362 1 15 SHEET 1 AA1 2 TYR A 11 VAL A 15 0 SHEET 2 AA1 2 THR A 19 LEU A 23 -1 O PHE A 20 N GLN A 14 SHEET 1 AA2 5 TYR A 26 GLY A 35 0 SHEET 2 AA2 5 GLY A 38 ASP A 45 -1 O ALA A 42 N LYS A 30 SHEET 3 AA2 5 ILE A 50 SER A 58 -1 O VAL A 54 N CYS A 41 SHEET 4 AA2 5 ASP A 103 GLU A 109 -1 O MET A 108 N ALA A 53 SHEET 5 AA2 5 ASN A 90 PHE A 92 -1 N PHE A 92 O TYR A 105 SHEET 1 AA3 3 ALA A 113 ASN A 114 0 SHEET 2 AA3 3 ILE A 157 VAL A 159 -1 O VAL A 159 N ALA A 113 SHEET 3 AA3 3 LEU A 165 ILE A 167 -1 O LYS A 166 N VAL A 158 LINK SG CYS A 116 C04 Y56 A 501 1555 1555 1.77 CRYST1 63.235 65.761 94.117 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015814 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015207 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010625 0.00000